Universe Pharmaceuticals Inc (UPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,672 | -8,727 | -6,581 | -8,737 | 11,320 |
| Depreciation Amortization | 517 | 486 | 509 | 534 | 447 |
| Income taxes - deferred | N/A | 607 | 1,568 | -605 | -668 |
| Accounts receivable | -169 | -1,548 | 4,718 | -1,549 | -3,868 |
| Accounts payable and accrued liabilities | -3,133 | 144 | 1,641 | -1,897 | 2,457 |
| Other Working Capital | -2,268 | -2,058 | 5,670 | 6,589 | -12,686 |
| Other Operating Activity | 3,672 | 1,590 | -6,409 | 4,353 | 942 |
| Operating Cash Flow | $-5,052 | $-9,507 | $1,117 | $-1,312 | $-2,056 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | -13,529 |
| PPE Investments | -261 | -244 | -44 | -93 | -11,074 |
| Net Acquisitions | N/A | N/A | N/A | -3,815 | N/A |
| Purchase Sale Intangibles | -80 | -117 | N/A | N/A | N/A |
| Other Investing Activity | -80 | -117 | 0 | 0 | -2,458 |
| Investing Cash Flow | $-342 | $-361 | $-44 | $-3,908 | $-27,060 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 10,271 | 17,317 | 2,579 | 7,591 | 3,389 |
| Common Stock Issued | 15,000 | 25,000 | N/A | N/A | 28,750 |
| Other Financing Activity | -15,545 | -8,363 | -3,970 | -4,273 | -5,557 |
| Financing Cash Flow | $9,726 | $33,954 | $-1,391 | $3,318 | $26,582 |
| Exchange Rate Effect | -238 | 126 | -108 | -464 | 554 |
| Beginning Cash Position | 29,498 | 5,285 | 5,712 | 8,078 | 10,058 |
| End Cash Position | 33,592 | 29,498 | 5,285 | 5,712 | 8,078 |
| Net Cash Flow | $4,094 | $24,213 | $-426 | $-2,367 | $-1,980 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,052 | -9,507 | 1,117 | -1,312 | -2,056 |
| Capital Expenditure | -267 | -246 | -44 | -94 | -11,074 |
| Free Cash Flow | -5,319 | -9,753 | 1,073 | -1,406 | -13,129 |